Stroke Outcomes at Novant Health

This vertical bar chart shows monthly performance data for Novant Health Forsyth Medical Center in meeting CSTK 08, which tracks the percentage of stroke patients who achieved TICI post treatement grade of 2b or 3. The chart spans January through December and compares monthly percentages (shown in purple bars) against two benchmarks: an median of 92% (green line) and the Joint Commission (TJC) certification requirement of 89% (gray line).

The overall goal, stated in bold green text above the chart, is to "achieve complete or near complete."

Below is the monthly performance with patient counts (n): January (n=19): 90%, February (n=7): 100%, March (n=13): 85%, April (n=14): 79%, May (n=9): 100%, June (n=14): 100%, July (n=13): 85%, August (n=15): 93%, September (n=12): 100%, October (n=5): 100%, November (n=5): 60%, December (n=17): 82%.

The chart highlights that while several months (February, May, June, September, October, and November) exceeded both the internal and TJC benchmarks, other months (March, April, July, and December) fell below both target lines, indicating variability in performance across the year.

This vertical bar chart shows monthly performance data for Novant Health Presbyterian Medical Center in meeting CSTK 11, which tracks the percentage of stroke patients who achieved TICI 2b reperfusion within 120 minutes of hospital arrival. The chart spans January through December and compares monthly percentages (shown in purple bars) against two benchmarks: an internal target of 80% (green line) and the Joint Commission (TJC) certification requirement of 76% (gray line).

The overall goal, stated in bold text above the chart, is to "restore blood flow after a brain blood clot within 120 minutes."

Below is the monthly performance with patient counts (n): January (n=5): 100%, February (n=4): 100%, March (n=7): 100%, April (n=4): 75%, May (n=9): 88%, June (n=4): 50%, July (n=6): 66%, August (n=5): 60%, September (n=11): 90%, October (n=7): 42%, November (n=5): 60%, December (n=2): 100%.

The chart highlights that while several months (January, February, March, May, September, and December) exceeded both the internal and TJC benchmarks, other months (June, July, August, October, and November) fell below both target lines, indicating variability in performance across the year.

This chart, titled “2024 Symptomatic CEA/CAS Complications/Mortality,” compares post-operative complication and 30-day mortality rates for three procedures at Novant Health Presbyterian Medical Center: CEA (Carotid Endarterectomy), CAS (Carotid Artery Stenting), and TCAR (Transcarotid Artery Revascularization), in patients with symptoms. The vertical axis displays percentages from 0% to 10%, and each procedure is represented along the horizontal axis. Purple bars show post-operative complication rates, yellow bars would indicate mortality (though none appear in this chart), and a red horizontal line marks the 6% benchmark for acceptable outcomes.

CEA had a 0% complication rate and 0% mortality, based on 20 procedures. 
CAS had a 7% complication rate with 0% mortality, based on 29 procedures. 
TCAR had the highest complication rate at 8%, also with 0% mortality, based on 12 procedures. 

Both CAS and TCAR exceeded the 6% benchmark, while CEA remained below it.

The chart highlights that for symptomatic patients, CAS and TCAR are associated with higher complication rates than the benchmark, while CEA had no observed complications or deaths.

This bar chart titled “2024 Asymptomatic CEA/CAS Complication/Mortality” compares complication and mortality rates for three carotid procedures at Novant Health Presbyterian Medical Center: CEA (Carotid Endarterectomy), CAS (Carotid Artery Stenting), and TCAR (Transcarotid Artery Revascularization). The vertical axis shows percentages from 0% to 10%, and each procedure is represented on the horizontal axis with bars indicating outcomes. Purple bars show the percentage of post-operative complications, yellow bars would represent 30-day mortality (though none appear in this chart), and red horizontal line marks the benchmark rate at 3% representing the acceptable complication threshold.

CEA had a 0% complication rate and 0% mortality, based on 40 procedures. 
CAS had a 0% complication rate with 0% mortality, based on 11 procedures. 
TCAR had the highest complication rate at 9%, also with 0% mortality, based on 21 procedures. 

Overall, the chart highlights that while CEA and CAS remained well below the complication benchmark, TCAR exceeded the target with a 9% complication rate, though mortality remained at 0% for all procedures.